Dr. Sarah Albert, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,234 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,406 | 24 | $0 (2023) |
| Amgen Inc. | $671.18 | 14 | $0 (2024) |
| ViiV Healthcare Company | $437.77 | 11 | $0 (2024) |
| GENZYME CORPORATION | $194.45 | 3 | $0 (2024) |
| ABBVIE INC. | $170.66 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $136.99 | 6 | $0 (2024) |
| Genentech USA, Inc. | $94.22 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $72.63 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $50.38 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $867.20 | 21 | Amgen Inc. ($432.98) |
| 2023 | $693.37 | 18 | ViiV Healthcare Company ($207.42) |
| 2022 | $1,530 | 32 | Novo Nordisk Inc ($1,301) |
| 2021 | $142.99 | 2 | ViiV Healthcare Company ($122.43) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Cardiology | ||||||
| 05/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Inflammation | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $22.18 | General |
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: HIV | ||||||
| 02/23/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $110.93 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: HIV | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Inflammation | ||||||
| 12/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $142.29 | General |
| Category: Immunology | ||||||
| 11/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Diabetes | ||||||
About Dr. Sarah Albert, MD
Dr. Sarah Albert, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1851886295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Albert, MD has received a total of $3,234 in payments from pharmaceutical and medical device companies, with $867.20 received in 2024. These payments were reported across 73 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,234).
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Bronx, NY
- Active Since 06/28/2018
- Last Updated 09/27/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1851886295
Products in Payments
- Rybelsus (Drug) $759.45
- Ozempic (Drug) $646.09
- Repatha (Biological) $397.02
- DOVATO (Drug) $315.34
- Otezla (Drug) $249.20
- DUPIXENT (Biological) $194.45
- QULIPTA (Drug) $170.66
- CABENUVA (Biological) $122.43
- LEQVIO (Drug) $114.64
- NUCALA (Biological) $72.63
- Xolair (Biological) $59.08
- PIFELTRO (Drug) $28.20
- TEZSPIRE (Biological) $24.96
- ENTRESTO (Drug) $22.35
- Actemra (Biological) $20.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107